Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02630472Phase 2Terminated
A Phase 2 trial of quinine in chronic rhinosinusitis (CRS), sponsored by University of Pennsylvania. Started Oct 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02630472.